Lv1
64 积分 2024-07-02 加入
Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia
9小时前
已完结
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers
15天前
已关闭
Selecting an Optimal Antibody for Antibody–Drug Conjugate Therapy
1个月前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
1个月前
已完结
The Characteristics and Outcomes of Adult Acute Myeloid Leukemia Patients With KMT2A ‐Partial Tandem Duplication
2个月前
已完结
Cancer Throughlines: 25 Years after First Approval, ADCs Continue to Pick up Steam
2个月前
已关闭
MEN1 mutations mediate clinical resistance to menin inhibition
2个月前
已完结
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer
2个月前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer
2个月前
已完结
Targeting the super elongation complex for oncogenic transcription driven tumor malignancies: Progress in structure, mechanisms and small molecular inhibitor discovery
2个月前
已完结
皖公网安备34019202002308
